ArticleArchives of medical science : AMS2013
The role of counselling and other factors in compliance of postmenopausal osteoporotic patients to alendronate 70 therapy.
Article in Archives of medical science : AMS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Evaluation of a "Just-in-Time" Nurse Consultation on Bone Health: A Pilot Randomized Controlled Trial.The Permanente journal · 2017Trial
- Article
- Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine.BMC women's health · 2022Article
- Influence of General Mineral Condition on Collagen-Guided Alveolar Crest Augmentation.Materials (Basel, Switzerland) · 2020Article
- Improving drug adherence in osteoporosis: an update on more recent studies.Therapeutic advances in musculoskeletal disease · 2018Review
- General self-efficacy level and health behaviours in women over the age of 45 years who have undergone osteoporosis treatment.Przeglad menopauzalny = Menopause review · 2017Article
- Evaluation of the quality of life of postmenopausal osteoporotic and osteopenic women with or without fractures.Archives of medical science : AMS · 2016Article
- Knowledge about osteoporosis prevention among women screened by bone densitometry.Przeglad menopauzalny = Menopause review · 2016Article
- Vitamin D receptor BsmI polymorphism and osteoporosis risk in post-menopausal women.Archives of medical science : AMS · 2016Review
- Long-term persistence with anti-osteoporosis drugs after fracture.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2015Article
- Chosen risk factors for osteoporosis and the level of knowledge about the disease in peri- and postmenopausal women.Przeglad menopauzalny = Menopause review · 2015Article
- Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis.Patient preference and adherence · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of the study was to assess the role of patient counselling, nurse assistance and effects of biochemical examinations in adherence of women with postmenopausal osteoporosis to alendronate 70 administration over 12 months of therapy. MATERIAL AND
methodsCompliance and persistence to alendronate 70 therapy were assessed in a prospective study of 123 postmenopausal women, followed up for one year. The patients were divided into 4 groups (controls, counselled group, biochemical group and nurse assisted group) with monitoring every 6 months; in the nurse assisted group, additional phone contacts were made after 3 and 9 months of treatment. After 12 months, compliance and persistence were analysed. The medication possession ratio (MPR) was regarded as optimal when its value exceeded 80%.
resultsThe compliance to alendronate 70 therapy was 54.03% in the control group and the mean persistence with medication was 197 days. The MPR above 80% was observed in 37.5%, and, after 1 year, 43.75% of patients were found persistent with the therapy. In the remaining groups, both compliance and persistence were higher but not statistically significantly, compared to the control group. Neither patient's age, education, diet, nor physical activity influenced the compliance with prescribed therapy. The most common reason to discontinue therapy was either its side effects or smoking.
conclusionsThe obtained results suggest that better adherence with medical recommendations is observed in patients who receive additional attention, e.g. counselling, biochemical tests or nursing care. The critical elements for therapy discontinuation were side effects and smoking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.